Case report
A 27-year-old woman received an allogeneic BMT from Reactivation of infections with herpes viruses is a frequent and major cause of morbidity after bone marrow her HLA-identical, MLC non-reactive sibling donor for treatment of progressive centroblastic-centrocytic lymtransplantation. In this case report we stress that HSV infections of the colon and small intestine should be conphoma (Kiel classification) in relapse refractory to conventional salvage chemotherapy. The patient was CMV antisidered in the differential diagnosis of diarrhea and intestinal bleeding in the early post-transplantation perbody negative and HSV antibody positive, and the donor was positive for anti-CMV-IgG and negative for HSV antiiod. Severe acute GVHD and subsequent intensive immunosuppressive treatment may increase the risk for bodies. The preparative regimen for BMT consisted of busulfan (10 mg/kg), thiotepa (750 mg/m 2 ) and cycloreactivation of HSV infection particularly in situations in which acyclovir prophylaxis has been omitted.
phosphamide (120 mg/kg). Graft-versus-host disease prophylaxis consisted of cyclosporin A and a short course Keywords: HSV; acute GVHD; intestinal bleeding of methotrexate on days +1, +3, +6 and +11. Acyclovir prophylaxis against herpes virus reactivation was started intravenously on day +1 (3 × 500 mg daily) and was disReactivation of infections with herpes viruses such as continued on day +19 during a period characterized by varicella zoster virus (VZV), cytomegalovirus (CMV), deteriorating renal function but concurrent rapid hematopoEpstein-Barr virus (EBV), or herpes simplex virus (HSV ietic engraftment. Intravenous immunoglobulin was given 1 and 2) is a frequent and major cause of morbidity after at 100 mg/kg on days −1, +7, +14 and biweekly thereafter. bone marrow transplantation. The reactivation of latent perShe gradually developed grade III acute GVHD involvsisting HSV occurs in 70% of seropositive patients usually ing skin, liver and the intestinal tract, manifesting with produring the first month after BMT. 1 Today, the introduction fuse watery diarrhea. Day +31 prednisone treatment was of prophylactic treatment with acyclovir has significantly initiated with 3 mg/kg i.v. daily. While skin manifestations decreased the incidence of both localized and systemic stabilized, diarrhea worsened. Repeated stool cultures for infections. Most patients developing clinically apparent disbacteria, Clostridium difficile toxin and fungi were negaease present with severe oral or genital mucositis and esotive. Consecutively, prednisone was increased to 15 mg/kg phagitis. Occasionally, dissemination of HSV can lead to i.v. for 3 days and subsequently rapidly tapered when life-threatening encephalitis, pneumonia or hepatitis. 1 Little GVHD had improved to grade II. However, on day +45 the is known about the role of HSV as a causative agent in diarrhea recurred and was associated with massive blood infectious enteritis with diarrhea occurring in the early postloss, requiring transfusion of 8 units of packed red blood transplantation period. Besides a variety of bacterial, fungal cells. Endoscopy was performed to localize the source of and protozoal microorganisms, CMV is the most frequent blood loss. The colon and stomach were unremarkable, viral agent responsible for enteritis. HSV infection of the whereas the duodenum was heavily diffusely inflamed but intestine is uncommon. 2 So far only six patients with intesnot bleeding. At that time, as no oral or nasolabial ulcertinal HSV infection (colitis in all of the cases) have been ations were present, oral cultures were not performed. reported in the literature. [3] [4] [5] [6] [7] We describe a BMT recipient Because of continuing blood loss from the jejunum as with severe acute graft-versus-host disease who experiidentified by digital subtraction angiography she was operenced HSV infection of the jejunum which led to serious ated on day +50. The jejunum was massively inflamed and diffuse mucosal damage and intestinal bleeding. bleeding diffusely; 14 cm of jejunum comprising the most affected area were resected. revealed necrosis of the entire mucosa (with no specific cell alterations such as inclusion bodies identifiable). The Early after BMT the occurrence of diarrhea is a common complication caused either by the conditioning therapy, submucosal layer was edematous, consistent with acute GVHD grade IV. Further immunohistochemical examinantibiotic treatment, GVHD, or by infections with various microorganisms. Fifty percent of patients with grade II to ation with a polyclonal antibody showed patchy areas of positivity for HSV antigens in the mucosal cells. The anti-IV acute GVHD have gastrointestinal involvement 8 which may lead to bleeding from the small intestine and the colon body used does not discriminate between HSV 1 and HSV 2 ( Figure 1) . PCR analysis for HSV 1 and HSV 2 was perif extensive ulceration of the mucosa is present. Patients presenting with intestinal bleeding due to acute GVHD of formed using a triple oligo PCR with three primers localized in the DNA polymerase region of the HSV 1 and the intestine have concurrent CMV infection in about half of the cases. 9 The close correlation of severity of GVHD, HSV 2 genome. Amplification of different sized fragments allows discrimination between HSV 1 and HSV 2. Whereas immunosuppressive treatment and the occurrence of CMV infection has been described by several groups, whereas weekly PCR analysis of buffy coat and serum remained negative for HSV 1 and HSV 2 throughout the clinical such a correlation is less well documented for HSV. There has been a report that donor seropositivity for HSV is assocourse, analysis of the jejunal biopsy and jejunal irrigation fluid revealed positivity for HSV1 and negativity for HSV ciated with a higher incidence of grade II-IV GVHD. 10 One BMT patient presented with GVHD and concomitant 2. It is of note that CMV infected cells could not be demonstrated and PCR analyses of buffy coat lysates were nega-HSV-, CMV-and Clostridium difficile infection of the colon. 7 HSV was grown from cecal biopsy cultures, but tive for CMV DNA throughout the total post-transplant period.
could not be confirmed by histopathology. As in our case, the clinical picture in this patient was complicated by the fact that GVHD was also present. Since reactivation of latent HSV infections after BMT is a well known phenomenon, patients routinely receive Discussion prophylactic treatment with acyclovir. Acyclovir administration in our patient was stopped 3 weeks after BMT, and In this case report we describe a patient with HSV 1 infection of the jejunum leading to diarrhea and death from 2 weeks after BMT in the patient described in Ref. 7 , which may have facilitated HSV reactivation. In situations of HSV uncontrolled intestinal bleeding. A literature search revealed six case reports about patients with HSV-associareactivation where continuing acyclovir prophylaxis is underway, development of acyclovir resistance has to be ted infection of the intestine. [3] [4] [5] [6] [7] However, in all of the patients reported colitis was diagnosed but the small intesconsidered.
In conclusion, HSV infections of the colon as well as tine was never affected. A common underlying problem in these patients was disturbance of the immune defense. One the small intestine may cause or contribute to the development of diarrhea in the early post-transplant period. Risk patient was a kidney transplant recipient, another suffered from Hodgkin's disease being treated with C-MOPP, a of reactivation appears to be increased during severe acute GVHD and the attendant immunosuppressive treatment and further patient was an HIV-positive homosexual man with opportunistic infections. Only one patient was a bone marin situations where acyclovir prophylaxis has been omitted or interrupted. row transplant recipient as our case. It is debatable, however likely, that the sixth patient, a 78-year-old woman, also had an impaired immune system. It is of note that three of the six patients showed additional general mucosal ulcers
